The clinical features of migraine-associated vertigo

Fumiyuki Goto, Tomoko Tsutsumi, Kaoru Ogawa

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Migraine-associated vertigo (MAV) is proposed as a new clinical entity on the basis of the assumption that the typical migraine and vertigo or dizziness have a common pathophysiology. Some of the patients with recurrent vertigo syndromes with unknown pathology may have MAV. We performed a retrospective study to clarify the clinical characteristics of MAV in the Japanese population. The following were considered as diagnostic criteria: (1) recurrent vestibular symptoms, (2) migraine headache as defined by the International Headache Society (IHS) criteria, (3) at least one instance of synchronization of a vertiginous attack with a migraine headache, (4) no associated unilateral hearing loss, and (5) absence of other diseases that may have caused vertiginous attacks. Of 552 patients with dizziness or vertigo, 46 (8.3%) were diagnosed as having MAV. A typical feature of this clinical entity is that migraine occurs before the onset of vertigo in women aged 30-40 years. Usually the attacks occur once in a year for 1 to 10 years. An attack lasts for 1-24 h and presents as vertigo and unsteadiness with simultaneous headache. The presence of hearing loss presents an important clinical dilemma. Whether the condition in patients experiencing hearing loss should be defined as MAV or not is still a matter for discussion.

Original languageEnglish
Pages (from-to)953-959
Number of pages7
JournalJournal of Otolaryngology of Japan
Volume116
Issue number8
Publication statusPublished - 2013 Aug

Fingerprint

Vertigo
Migraine Disorders
Dizziness
Hearing Loss
Headache
Unilateral Hearing Loss
Retrospective Studies
Pathology

Keywords

  • Clinical feature
  • Diagnosis
  • Migraine-associated vertigo

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

The clinical features of migraine-associated vertigo. / Goto, Fumiyuki; Tsutsumi, Tomoko; Ogawa, Kaoru.

In: Journal of Otolaryngology of Japan, Vol. 116, No. 8, 08.2013, p. 953-959.

Research output: Contribution to journalArticle

Goto, Fumiyuki ; Tsutsumi, Tomoko ; Ogawa, Kaoru. / The clinical features of migraine-associated vertigo. In: Journal of Otolaryngology of Japan. 2013 ; Vol. 116, No. 8. pp. 953-959.
@article{7f4ce07ad55140a5b0a858eccc4d6321,
title = "The clinical features of migraine-associated vertigo",
abstract = "Migraine-associated vertigo (MAV) is proposed as a new clinical entity on the basis of the assumption that the typical migraine and vertigo or dizziness have a common pathophysiology. Some of the patients with recurrent vertigo syndromes with unknown pathology may have MAV. We performed a retrospective study to clarify the clinical characteristics of MAV in the Japanese population. The following were considered as diagnostic criteria: (1) recurrent vestibular symptoms, (2) migraine headache as defined by the International Headache Society (IHS) criteria, (3) at least one instance of synchronization of a vertiginous attack with a migraine headache, (4) no associated unilateral hearing loss, and (5) absence of other diseases that may have caused vertiginous attacks. Of 552 patients with dizziness or vertigo, 46 (8.3{\%}) were diagnosed as having MAV. A typical feature of this clinical entity is that migraine occurs before the onset of vertigo in women aged 30-40 years. Usually the attacks occur once in a year for 1 to 10 years. An attack lasts for 1-24 h and presents as vertigo and unsteadiness with simultaneous headache. The presence of hearing loss presents an important clinical dilemma. Whether the condition in patients experiencing hearing loss should be defined as MAV or not is still a matter for discussion.",
keywords = "Clinical feature, Diagnosis, Migraine-associated vertigo",
author = "Fumiyuki Goto and Tomoko Tsutsumi and Kaoru Ogawa",
year = "2013",
month = "8",
language = "English",
volume = "116",
pages = "953--959",
journal = "Journal of Otolaryngology of Japan",
issn = "0030-6622",
publisher = "Oto-Rhino-Laryngological Society of Japan Inc.",
number = "8",

}

TY - JOUR

T1 - The clinical features of migraine-associated vertigo

AU - Goto, Fumiyuki

AU - Tsutsumi, Tomoko

AU - Ogawa, Kaoru

PY - 2013/8

Y1 - 2013/8

N2 - Migraine-associated vertigo (MAV) is proposed as a new clinical entity on the basis of the assumption that the typical migraine and vertigo or dizziness have a common pathophysiology. Some of the patients with recurrent vertigo syndromes with unknown pathology may have MAV. We performed a retrospective study to clarify the clinical characteristics of MAV in the Japanese population. The following were considered as diagnostic criteria: (1) recurrent vestibular symptoms, (2) migraine headache as defined by the International Headache Society (IHS) criteria, (3) at least one instance of synchronization of a vertiginous attack with a migraine headache, (4) no associated unilateral hearing loss, and (5) absence of other diseases that may have caused vertiginous attacks. Of 552 patients with dizziness or vertigo, 46 (8.3%) were diagnosed as having MAV. A typical feature of this clinical entity is that migraine occurs before the onset of vertigo in women aged 30-40 years. Usually the attacks occur once in a year for 1 to 10 years. An attack lasts for 1-24 h and presents as vertigo and unsteadiness with simultaneous headache. The presence of hearing loss presents an important clinical dilemma. Whether the condition in patients experiencing hearing loss should be defined as MAV or not is still a matter for discussion.

AB - Migraine-associated vertigo (MAV) is proposed as a new clinical entity on the basis of the assumption that the typical migraine and vertigo or dizziness have a common pathophysiology. Some of the patients with recurrent vertigo syndromes with unknown pathology may have MAV. We performed a retrospective study to clarify the clinical characteristics of MAV in the Japanese population. The following were considered as diagnostic criteria: (1) recurrent vestibular symptoms, (2) migraine headache as defined by the International Headache Society (IHS) criteria, (3) at least one instance of synchronization of a vertiginous attack with a migraine headache, (4) no associated unilateral hearing loss, and (5) absence of other diseases that may have caused vertiginous attacks. Of 552 patients with dizziness or vertigo, 46 (8.3%) were diagnosed as having MAV. A typical feature of this clinical entity is that migraine occurs before the onset of vertigo in women aged 30-40 years. Usually the attacks occur once in a year for 1 to 10 years. An attack lasts for 1-24 h and presents as vertigo and unsteadiness with simultaneous headache. The presence of hearing loss presents an important clinical dilemma. Whether the condition in patients experiencing hearing loss should be defined as MAV or not is still a matter for discussion.

KW - Clinical feature

KW - Diagnosis

KW - Migraine-associated vertigo

UR - http://www.scopus.com/inward/record.url?scp=84883324573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883324573&partnerID=8YFLogxK

M3 - Article

C2 - 24044171

AN - SCOPUS:84883324573

VL - 116

SP - 953

EP - 959

JO - Journal of Otolaryngology of Japan

JF - Journal of Otolaryngology of Japan

SN - 0030-6622

IS - 8

ER -